CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to TLPH

Zalviso™

Phase 3
TALPHERA, INC. (TLPH)

Phase 3

Development Phase

0

Upcoming Catalysts

0

Historical Events

1

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Moderate-to-severe Acute Pain

View Full Landscape
Drug Information

Target Indication

Moderate-to-severe Acute Pain

Clinical Trial

NCT02662764

Last updated: 10/16/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Regulatory Approvals
EMA9/18/2015

Zalviso

Zalviso is indicated for the management of acute moderate to severe post-operative pain in adult patients.

View on EMA
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.